MUC16 and female reproductive organ cancer: Overall, while our data suggest limited value for CA-125 in detecting early gynecological cancers in WLWH, further studies involving larger and more diverse cohorts are needed to fully evaluate its potential role, either alone or in combination with other biomarkers, in this high-risk population.